BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34775859)

  • 1. Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Level is Related to Clinical Prognosis In Patients with Acute Atherosclerosis-related Ischemic Stroke.
    Yang X; Hou D; Liu J; Wang T; Luo Y; Sun W; Li C; Shen L; Liu W; Wu D
    Clin Appl Thromb Hemost; 2021; 27():10760296211059500. PubMed ID: 34775859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Degree of Plasma Oxidized Low-Density Lipoprotein Level Decrease Is Related to Clinical Outcomes for Patients with Acute Ischemic Stroke.
    Yang X; Sun W; Hou D; Wang T; Li C; Luo Y; Zhang S; Shen L; Liu W; Wu D
    Dis Markers; 2021; 2021():4998823. PubMed ID: 34950249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel biomarker for large-artery atherosclerotic stroke.
    Huang W; Li Q; Chen X; Lin Y; Xue J; Cai Z; Zhang W; Wang H; Jin K; Shao B
    Int J Neurosci; 2017 Oct; 127(10):881-886. PubMed ID: 27967338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke.
    Markstad H; Edsfeldt A; Yao Mattison I; Bengtsson E; Singh P; Cavalera M; Asciutto G; Björkbacka H; Fredrikson GN; Dias N; Volkov P; Orho-Melander M; Nilsson J; Engström G; Gonçalves I
    J Am Heart Assoc; 2019 Feb; 8(4):e009874. PubMed ID: 30744454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study.
    Yokota C; Sawamura T; Watanabe M; Kokubo Y; Fujita Y; Kakino A; Nakai M; Toyoda K; Miyamoto Y; Minematsu K
    J Atheroscler Thromb; 2016 Oct; 23(10):1222-1226. PubMed ID: 27025681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of sLOX-1 in intracranial artery stenosis and in predicting long-term prognosis of acute ischemic stroke.
    Li XM; Jin PP; Xue J; Chen J; Chen QF; Luan XQ; Zhang ZR; Yu TE; Cai ZY; Zhao K; Shao B
    Brain Behav; 2018 Jan; 8(1):e00879. PubMed ID: 29568681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke.
    Zheng Y; Huang Y; Li L; Wang P; Wang R; Tao Z; Fan J; Han Z; Li F; Zhao H; Zhao F; Yan F; Liu Y; Luo Y
    Neural Plast; 2021; 2021():6718184. PubMed ID: 34497641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack.
    Skarpengland T; Skjelland M; Kong XY; Skagen K; Holm S; Otterdal K; Dahl CP; Krohg-Sørensen K; Sagen EL; Bjerkeli V; Aamodt AH; Abbas A; Gregersen I; Aukrust P; Halvorsen B; Dahl TB
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29330254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble lectin-like oxidized low-density Lipoproteinreceptor-1 and recurrent stroke: A nested case-control study.
    Wang A; Tian X; Xu J; Li H; Xu Q; Chen P; Meng X; Wang Y
    CNS Neurosci Ther; 2022 Dec; 28(12):2001-2010. PubMed ID: 35909324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 as a biomarker of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Lin Q; Ba HJ; Dai JX; Sun J; Lu C; Chen MH; Chen XD; Cai JY
    Brain Behav; 2020 Feb; 10(2):e01517. PubMed ID: 31943892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) in the postmortem diagnosis of ischemic heart disease.
    Takasu S; Matsumoto S; Kanto Y; Iwadate K
    J Forensic Leg Med; 2018 Apr; 55():45-51. PubMed ID: 29462743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.
    Kraler S; Wenzl FA; Georgiopoulos G; Obeid S; Liberale L; von Eckardstein A; Muller O; Mach F; Räber L; Losdat S; Schmiady MO; Stellos K; Stamatelopoulos K; Camici GG; Srdic A; Paneni F; Akhmedov A; Lüscher TF
    Eur Heart J; 2022 May; 43(19):1849-1860. PubMed ID: 35567560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.
    Dey AK; Gaddipati R; Elnabawi YA; Ongstad E; Goyal A; Chung JH; Teague HL; Rodante JA; Sajja AA; Sorokin AV; Lateef SS; Aksentijevich M; Choi H; Reddy AS; Varghese NJ; Groenendyk J; Belur AD; Genovese L; Rivers JP; Lerman J; Kabbany MT; Harrington C; Ortiz J; Khalil N; Keel A; Baumer Y; Chen MY; Bluemke DA; Joshi AA; Kaplan MJ; Remaley AT; Playford MP; Karathanasis SK; Gelfand JM; Gupta R; Mehta NN
    JAMA Dermatol; 2020 Feb; 156(2):151-157. PubMed ID: 31746956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease.
    Kott KA; Genetzakis E; Gray MP; Hansen P; McGuire HM; Yang JY; Grieve SM; Vernon ST; Figtree GA
    Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: A multicentre pilot study.
    Zhao ZW; Xu YW; Li SM; Guo JJ; Yi T; Chen LL
    Biochem Med (Zagreb); 2019 Feb; 29(1):010705. PubMed ID: 30799974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with erectile dysfunction in patients without known coronary artery disease.
    Kobat MA; Fırdolas F; Balin M; Çelik A; Bentli R; Baydas A
    J Sex Med; 2013 Nov; 10(11):2782-9. PubMed ID: 23088332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study.
    Kume N; Mitsuoka H; Hayashida K; Tanaka M; Kita T
    Circ J; 2010 Jul; 74(7):1399-404. PubMed ID: 20467154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Original contribution: sleeve gastrectomy reduces soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) levels in patients with morbid obesity.
    Taskin HE; Kocael A; Kocael P; Zengin K; Al M; Sozer V; Buchwald JN; McGlennon TW; Uzun H
    Surg Endosc; 2022 Apr; 36(4):2643-2652. PubMed ID: 35044516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome.
    Stankova T; Delcheva G; Maneva A; Vladeva S
    Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31443320
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel prognostic biomarker in patients with ST-segment elevation acute myocardial infarction.
    Higuma T; Abe N; Tateyama S; Endo T; Shibutani S; Yokoyama H; Hanada K; Yamada M; Tomita H; Hanada H; Osanai T; Kume N; Okumura K
    Circ J; 2015; 79(3):641-8. PubMed ID: 25746549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.